News chronological

Showing 10 items before 1111788

Filters Applied:

NPR (Will Stone) - FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.

AXIOS (Caitlin Owens) - Longevity medicine's do-or-die moment

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one of the longevity field's most promising theories. Why it matters: The early-stage clinical trial will signal whether "cellular reprogramming" can be performed safely in humans, a prerequisite for any future claim that a treatment can slow or even reverse biological aging. The big picture: Attempts to prolong the human lifespan can refer to anything from better diet and exercise to the infusion of blood plasma from young donors. - The former is validated by decades of science; the latter has merited two warnings from the Food and Drug Administration that said such treatments lack any evidence of clinical benefit. …

NYTIMES (Silvia Benedetti and Andrea Hernández) - In Venezuela, a 91-Year-Old Weaver Sticks to Traditions

Though electric machines are now standard, the Venezuelan weaver Margarita Mora has clung to a mix of ancestral Indigenous and Spanish practices to create surprisingly modern work.